Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guojun Hao

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical Case Reports|April 22, 2026
Occlusion and Vascular Malformation Solved by a Novel Recanalization Management in a Hemodialysis Patient: A Case ReportGuojun Hao, Aihua Xie, Bin Tang, et al.
Frontiers in Immunology|July 19, 2024
Nephrotoxicity of targeted therapy used to treat lung cancerQiuling Li, Jieshan Lin, Guojun Hao, et al.
Experimental and Therapeutic Medicine|March 7, 2019
Erratum: Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysisYanli Liu, Jun Xiao, Xintian Shi, et al.
International Urology and Nephrology|March 20, 2019
MiR-200a ameliorates peritoneal fibrosis and functional deterioration in a rat model of peritoneal dialysisXin Wei, Yi Bao, Xiaojiang Zhan, et al.
Experimental and Therapeutic Medicine|February 19, 2016
Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysisYanli Liu, Jun Xiao, Xintian Shi, et al.
Polymers|October 16, 2024
Composite Fiber Wrapping Techniques for Enhanced Concrete MechanicsZhongxu Li, Guojun Hao, Haoran Du, et al.
Gene|April 2, 2015
The expression profiling and ontology analysis of noncoding RNAs in peritoneal fibrosis induced by peritoneal dialysis fluidYanli Liu, Runsheng Guo, Guojun Hao, et al.
Vascular|March 28, 2024
Risk factors for repeated percutaneous transluminal angioplasty of hemodialysis vascular access after initial interventionBin Tang, Yuwan Xiong, Yingxue Zhong, et al.
American Journal of Physiology. Renal Physiology|January 24, 2018
MiR-200a negatively regulates TGF-β<sub>1</sub>-induced epithelial-mesenchymal transition of peritoneal mesothelial cells by targeting ZEB1/2 expressionRunsheng Guo, Guojun Hao, Yi Bao, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Case Reports|April 22, 2026
Occlusion and Vascular Malformation Solved by a Novel Recanalization Management in a Hemodialysis Patient: A Case ReportGuojun Hao, Aihua Xie, Bin Tang, et al.
Frontiers in Immunology|July 19, 2024
Nephrotoxicity of targeted therapy used to treat lung cancerQiuling Li, Jieshan Lin, Guojun Hao, et al.
Experimental and Therapeutic Medicine|March 7, 2019
Erratum: Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysisYanli Liu, Jun Xiao, Xintian Shi, et al.
International Urology and Nephrology|March 20, 2019
MiR-200a ameliorates peritoneal fibrosis and functional deterioration in a rat model of peritoneal dialysisXin Wei, Yi Bao, Xiaojiang Zhan, et al.
Experimental and Therapeutic Medicine|February 19, 2016
Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysisYanli Liu, Jun Xiao, Xintian Shi, et al.
Polymers|October 16, 2024
Composite Fiber Wrapping Techniques for Enhanced Concrete MechanicsZhongxu Li, Guojun Hao, Haoran Du, et al.
Gene|April 2, 2015
The expression profiling and ontology analysis of noncoding RNAs in peritoneal fibrosis induced by peritoneal dialysis fluidYanli Liu, Runsheng Guo, Guojun Hao, et al.
Vascular|March 28, 2024
Risk factors for repeated percutaneous transluminal angioplasty of hemodialysis vascular access after initial interventionBin Tang, Yuwan Xiong, Yingxue Zhong, et al.
American Journal of Physiology. Renal Physiology|January 24, 2018
MiR-200a negatively regulates TGF-β<sub>1</sub>-induced epithelial-mesenchymal transition of peritoneal mesothelial cells by targeting ZEB1/2 expressionRunsheng Guo, Guojun Hao, Yi Bao, et al.
Pageof 1